Reading Time: 2 minutesIntroduction Age-related hearing loss (ARHL), or presbycusis, is a common condition affecting a significant portion of the American male population as they age. This progressive decline in auditory function can severely impact quality of life, communication, and overall well-being. Recent research has begun to explore innovative treatments to mitigate the effects of ARHL, with sermorelin emerging as a promising candidate. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), has been traditionally used to stimulate the production of growth hormone in the body. However, its potential benefits in otology, particularly in improving hearing and ear health, warrant further investigation. This … Continue reading →